These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6275292)

  • 1. Multiple opiate receptors: differential binding of mu, kappa and delta agonists.
    Wood PL; Charleson SE; Lane D; Hudgin RL
    Neuropharmacology; 1981 Dec; 20(12A):1215-20. PubMed ID: 6275292
    [No Abstract]   [Full Text] [Related]  

  • 2. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential postnatal development of mu and delta opiate receptors.
    Wohltmann M; Roth BL; Coscia CJ
    Brain Res; 1982 Apr; 255(4):679-84. PubMed ID: 6280810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of beta-casomorphins with multiple opioid receptors: in vitro and in vivo studies in the newborn rat brain.
    Volterra A; Restani P; Brunello N; Galli CL; Racagni G
    Brain Res; 1986 Nov; 395(1):25-30. PubMed ID: 3022888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of amino-terminal sequence of beta-endorphin and dynorphin in the determination of opiate receptor type selectivity.
    Chang JK; Chang KJ
    Life Sci; 1983; 33 Suppl 1():267-9. PubMed ID: 6141489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICI 197067 is a selective ligand for the U-69593-sensitive kappa opiate binding site.
    Nock B; Giordano AL; Cicero TJ
    Eur J Pharmacol; 1989 Mar; 162(2):385-6. PubMed ID: 2542063
    [No Abstract]   [Full Text] [Related]  

  • 7. Endogenous opioid peptides: comparative evaluation of their receptor affinities in the mouse brain.
    Garzón J; Sánchez-Blázquez P; Höllt V; Lee NM; Loh HH
    Life Sci; 1983; 33 Suppl 1():291-4. PubMed ID: 6319879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential association of spinal mu, delta and kappa opioid receptors with cutaneous thermal and visceral chemical nociceptive stimuli in the rat.
    Schmauss C; Yaksh TL; Shimohigashi Y; Harty G; Jensen T; Rodbard D
    Life Sci; 1983; 33 Suppl 1():653-6. PubMed ID: 6319919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple opiate receptors: support for unique mu, delta and kappa sites.
    Wood PL
    Neuropharmacology; 1982 Jun; 21(6):487-97. PubMed ID: 6287334
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoradiographic localization of benzomorphan binding sites in rat brain.
    Crain BJ; Valdes F; Chang KJ; McNamara JO
    Eur J Pharmacol; 1985 Jul; 113(2):179-86. PubMed ID: 2995063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic effects of mu-, delta- and kappa-opiate agonists and, in particular, dynorphin at the spinal level.
    Przewłocki R; Stala L; Greczek M; Shearman GT; Przewłocka B; Herz A
    Life Sci; 1983; 33 Suppl 1():649-52. PubMed ID: 6141505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid activities of human beta-casomorphins.
    Koch G; Wiedemann K; Teschemacher H
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):351-4. PubMed ID: 3005882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed type inhibition of [D-Ala2, D-Leu5]enkephalin binding to mu-opiate binding sites by mu-, but not by kappa-opiate ligands.
    Pfeiffer A; Herz A
    Eur J Pharmacol; 1982 Feb; 77(4):359-61. PubMed ID: 6277680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent labeling of opioid receptors with radioiodinated human beta-endorphin. Identification of binding site subunit.
    Howard AD; de La Baume S; Gioannini TL; Hiller JM; Simon EJ
    J Biol Chem; 1985 Sep; 260(19):10833-9. PubMed ID: 2993292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate binding properties of naturally occurring N- and C-terminus modified beta-endorphins.
    Akil H; Young E; Watson SJ; Coy DH
    Peptides; 1981; 2(3):289-92. PubMed ID: 6272244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prenatal development profile of expression of opioid peptides and receptors in the mouse brain.
    Rius RA; Barg J; Bem WT; Coscia CJ; Loh YP
    Brain Res Dev Brain Res; 1991 Feb; 58(2):237-41. PubMed ID: 1674235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different types of opiate agonists interact distinguishably with mu, delta and kappa opiate binding sites.
    Pfeiffer A; Herz A
    Life Sci; 1982 Sep 20-27; 31(12-13):1355-8. PubMed ID: 6128658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for G-protein-coupled epsilon receptor in the brain of triple opioid receptor knockout mouse.
    Contet C; Matifas A; Kieffer BL
    Eur J Pharmacol; 2004 May; 492(2-3):131-6. PubMed ID: 15178356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of opiate receptor number in vivo: simultaneous kappa-receptor down-regulation and mu-receptor up-regulation following chronic agonist/antagonist treatment.
    Morris BJ; Herz A
    Neuroscience; 1989; 29(2):433-42. PubMed ID: 2542839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL; Zarr GD; Brown SR; Cox BM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.